aldesleukin
Ligand Summary
a recombinant human IL-2, marketed for the treatment of metastatic renal cell carcinoma; BAY 50-4798 is a variant
ChEMBL: CHEMBL1201438
DrugCentral: 5011
LyCHI: aldesleukin
Target Activities
3 Activities
Items per page:
1 – 3 of 3
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
AGONIST | ||||||
AGONIST | ||||||
AGONIST | ||||||